The use of vancomycin in the treatment of adult patients with methicillin-resistant Staphylococcus aureus (MRSA) infection: a survey in a tertiary hospital in China.

Journal: International journal of clinical and experimental medicine
Published Date: Oct 15, 2015

Abstract

BACKGROUND: Vancomycin is frequently used in the treatment of methicillin-resistant Staphylococcus aureus (MRSA).

Authors

  • Jing Tang
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Jiali Hu
    Department of Clinical Pharmacy, Shanghai First People's Hospital, Shanghai Jiao Tong University Shanghai 201620, PR China.
  • Lei Kang
    Department of Clinical Pharmacy, Shanghai First People's Hospital, Shanghai Jiao Tong University Shanghai 201620, PR China.
  • Zhengjun Deng
    Department of Clinical Pharmacy, Shanghai First People's Hospital, Shanghai Jiao Tong University Shanghai 201620, PR China.
  • Jiaofen Wu
    Department of Clinical Pharmacy, Shanghai First People's Hospital, Shanghai Jiao Tong University Shanghai 201620, PR China.
  • Jiaqian Pan
    Department of Clinical Pharmacy, Shanghai First People's Hospital, Shanghai Jiao Tong University Shanghai 201620, PR China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals